Mom's Story, A Child Learns About MS

Mom's Story, A Child Learns About MS
Available on Amazon and www.marynickum.com

Saturday, March 14, 2020

The Coronavirus and MS: What You Need to Know

Reviewed by MSAA Chief Medical Officer Barry A. Hendin, MD

Symptoms and Special Considerations for Individuals with MS

The “coronavirus disease 2019” (COVID-19) is a potentially serious respiratory disease that was first reported in December 2019 in China. As of early March 2020, the illness had made its way to almost 70 locations, including the United States, and has affected more than 90,000 individuals worldwide. Please be aware that these figures are expected to increase on a weekly or even a daily basis.
If exposed to this new coronavirus, symptoms may appear within two days to two weeks. Initial symptoms include:
  • Fever
  • Cough
  • Shortness of breath
According to the Centers for Disease Control and Prevention (CDC), individuals showing signs of the disease should isolate themselves from other people and animals, and immediately contact their physician. Unless a medical emergency, those affected should not go directly to a medical facility. This is in an effort to avoid spreading the illness to others and to enable the physician to be prepared when a patient with this illness arrives at the office.
The majority of individuals who catch the coronavirus will not experience a serious form of the illness and will not need to be hospitalized. Seniors (ages 60 years and older) as well as individuals with certain health conditions such as heart disease, lung disease/respiratory illness, and diabetes, seem to be at greater risk of serious illness.
Those at greater risk also include people whose immune systems are suppressed, such as individuals who take disease-modifying therapies (DMTs) to treat MS, as well as those with other illnesses that compromise the immune system and/or require similar medications. People with MS should not stop taking their DMT, or make any changes to their treatment regimen, without consulting their physician.
Another consideration for individuals with MS is the fact that an illness, infection, or particularly a fever, can cause a temporary flare-up of symptoms, known as a pseudoexacerbation. If ill with a flu or virus, people with MS and their care partners should be aware of this potential complication. A pseudoexacerbation is a temporary worsening of symptoms without actual myelin inflammation or damage, brought on by other influences. Once the illness, infection, or fever is resolved, the flare-up will usually remit within 24 hours.

For anyone whose illness is more severe, especially if affecting the ability to breathe or if the fever is high, he or she (or the care partner) should immediately contact a medical professional or call 911 and explain the situation. Immediate emergency assistance may be needed.


How is the Coronavirus Spread?

According to the CDC, the virus is thought to spread mainly from person-to-person. This may occur between people who are in close contact with one another (within about six feet) and respiratory droplets produced when an infected person coughs or sneezes can land in the mouths or noses of people who are nearby. These droplets may also possibly be inhaled into the lungs.
People are thought to be the most contagious when they are their sickest, when experiencing the most symptoms. Additionally, the CDC notes that some spread might be possible before people show symptoms, but this is not thought to be the main way the virus spreads.
The virus may also spread from contact with infected surfaces or objects when someone with the illness has left germs on those surfaces by touching, sneezing, or coughing. When a healthy person touches an infected surface, and then touches his or her own mouth, nose, or eyes, it is possible that the virus may be spread this way. However, it is not thought to be the main way the virus spreads.
Some reports have questioned if the coronavirus may be caught through packages sent through the mail or products imported from areas with high numbers of cases. Several sources, including the CDC, state that germs could not live long enough on a mailed package to be a threat and that the risk is very low.

What to Do if Mildly Sick with the Coronavirus

As noted earlier, the majority of individuals who catch the coronavirus will not experience a serious form of the illness and will not need to be hospitalized. To follow are guidelines issued by the CDC for those who are mildly ill and are able to be isolated at home during their illness. However, a healthcare professional should immediately be contacted to determine (1) an individual’s illness severity and (2) to assess whether the residential setting is appropriate for home care.
Considerations include:
  • The patient (with coronavirus) is stable enough to receive care at home
  • Appropriate caregivers are available at home
  • The patient can recover in a separate bedroom, without sharing immediate space with others
  • Resources for access to food and other necessities are available
  • The patient and other household members have access to personal protective equipment (at a minimum, gloves and facemask) and are capable of adhering to recommended precautions, such as respiratory hygiene, cough etiquette, and hand hygiene
  • No household members are present who are at an increased risk of complications from a coronavirus infection; these include individuals who are 65 or older, young children, pregnant women, people who are immunocompromised, or those who have chronic heart, lung, or kidney conditions
The CDC lists the following recommendations if mildly sick with the coronavirus and able to be isolated and recover at home:
  • Stay home except to get medical care
  • People who are mildly ill and able to isolate at home during their illness should restrict activities outside of the home, except for getting medical care; do not go to work, school, or public areas; avoid using public transportation, ride-sharing, or taxis
  • At home, separate from other people and animals
  • Stay in a specific room at home and away from other people; use a separate bathroom if available
  • Restrict contact with pets and other animals while sick with COVID-19 until more information is known about the virus; avoid petting, snuggling, being kissed or licked, and sharing food
  • When possible, have another household member care for the animals; if no one is available, wash hands before and after interacting with pets and wear a facemask
  • Call ahead before visiting one’s doctor
  • If a medical appointment is planned, call the healthcare provider and explain the situation; this will help the healthcare provider’s office take steps to keep other people from getting infected or exposed
  • Wear a facemask when around other people, pets, and before entering a healthcare provider’s office; if unable to wear a facemask, others should not stay in the same room or they should wear a facemask if entering the room

Staying Healthy and Minimizing the Spread of COVID-19

The federal government and the CDC are proactively working to minimize the introduction and spread of this virus within the United States. More time is needed for researchers to gain a greater understanding of the specific virus (SARS-CoV-2) that causes this specific coronavirus (COVID-19), before a vaccine and treatments may be developed. Until these become available, the CDC explains that “Nonpharmaceutical Interventions” (NPIs) are actions that people and communities can take to help slow the spread of illnesses.
Also known as “community mitigation strategies,” and independent of medications and vaccines, examples of these types of actions include disinfecting surfaces, washing hands, staying home when sick, increasing the distance between people at public gatherings, canceling or postponing special events, and closing schools and/or businesses as needed. Avoiding travel to affected countries, as well as keeping a distance from anyone showing symptoms of the coronavirus, is also vital to minimizing the spread of the coronavirus.
Staying healthy and reducing one’s risk is another important factor. The CDC and MSAA recommend the following “healthy habits” for preventing the flu (and other illnesses):
  • Get a flu vaccine and help stop the spread of germs (if recommended by one’s doctor)
  • Continue taking a disease-modifying therapy (DMT) and do not make any changes to one’s treatment regimen, unless advised by one’s physician; consult a medical professional with any concerns
  • Take flu antivirals, if prescribed
  • Avoid close contact with people who are sick
  • Stay home when sick, but be sure to consult a medical professional
  • Individuals should cover their mouth and nose with a tissue when coughing or sneezing, or use the inside of their arm to avoid spreading germs
  • Washing hands often helps to protect people from germs; if soap and water are not available, an alcohol-based hand rub should be used
  • Avoid touching the eyes, nose, or mouth – an illness may be spread when a person touches something that is contaminated with germs and then touches his or her eyes, nose, or mouth
  • Practice other good health habits, such as cleaning and disinfecting frequently touched surfaces at home, work, or school – especially when someone is ill; get plenty of sleep, be physically active, manage stress, drink plenty of fluids, and eat nutritious food
  • Anyone in close contact to someone with COVID-19 and who develops symptoms of COVID-19 should immediately call his or her healthcare provider to discuss symptoms and exposure

Coronavirus Background and Overview

As noted earlier, the “coronavirus disease 2019” (COVID-19) is a potentially serious respiratory disease that was first reported in December 2019 in China. As of early March, 2020, the illness has made its way to almost 70 locations, including the United States, and has affected more than 90,000 individuals worldwide. Please be aware that these figures are expected to increase on a weekly or even a daily basis.
According to the Centers for Disease Control and Prevention (CDC), this new virus that causes the COVID-19 disease has been named “SARS-CoV-2,” and is part of a large family of coronaviruses that are common in people and many different species of animals, including camels, cattle, cats, and bats. The CDC explains that although rare, animal coronaviruses can occasionally infect people and then spread between people. Since the outbreak began in an area of China that has large seafood and live-animal markets, an initial animal-to-person spread is suggested. From there, the increasing number of people being diagnosed in areas without exposure to animal markets indicates a change to a person-to-person spread.
The coronavirus ranges from mild to severe. A report from China estimates that 16% of those diagnosed will experience a serious illness, so the majority of those affected will experience a milder form of the disease. The CDC notes that older people and individuals with certain health conditions such as heart disease, lung disease, and diabetes, seem to be at greater risk of serious illness.
According to the CDC, no scientific reports have been published about the susceptibility of pregnant women to the current coronavirus. Pregnant women do experience immunologic and physiologic changes that may make them more susceptible to viral respiratory infections, including COVID-19. No evidence indicates that children are more susceptible to this virus, and most confirmed cases of COVID-19 reported from China have occurred in adults.
Those at greater risk also include people whose immune systems are suppressed, such as individuals who take disease-modifying therapies (DMTs) to treat MS, as well as those with other illnesses that compromise the immune system and/or require similar medications. People with MS should not stop taking their DMT, or make any changes to their treatment regimen, without consulting their physician.
Despite the current warnings, the CDC states, “At this time, however, most people in the United States will have little immediate risk of exposure to this virus. This virus is NOT currently spreading widely in the United States. However, it is important to note that current global circumstances suggest it is likely that this virus will cause a pandemic. This is a rapidly evolving situation and the risk assessment will be updated as needed.”
An illness is considered a “pandemic” when it meets the following criteria: causing an illness that has resulted in death; sustained person-to-person spread, and worldwide spread of the new virus.

Closing Notes

MSAA’s Chief Medical Officer Barry A. Hendin, MD, explains that members of the MS community need to be aware of the risks and take extra steps to minimize their chances of catching the coronavirus. “Although only a small number of individuals in the United States have tested positive for the coronavirus, this number may increase exponentially in the coming weeks. People 60 and older, as well as those with certain health conditions or weakened immune systems, need to be particularly careful.
“Many individuals with MS take a disease-modifying therapy to control disease activity, and as is often the case with these types of disease-fighting medications, the immune system becomes suppressed and may be challenged to combat germs and infections. Even those who are not on a long-term treatment for MS may be more susceptible to infections and less able to fight-off illness. For these reasons, members of the MS community – including patients, care partners, and family members – need to be extra careful during this flu season to avoid catching the coronavirus and giving it to others.
“Strategies such as avoiding crowded public places, washing hands often, and keeping a distance from anyone who may appear to be sick are all vital to reducing your risk of catching the coronavirus. Remembering not to touch your eyes, nose, or mouth when in public and touching the same door handles, chair arms, and other things that multiple people have touched is also important. While we don’t want people to feel they are being held captive in their own homes – and we of course encourage individuals to go outside and be active – it may be wise at this time for people to temporarily avoid the more crowded types of activities and events.
“Unfortunately, this may mean reducing your time doing the things you may truly enjoy, such as shopping, going to the gym, and even attending educational programs. Waiting for things to settle down and become less of a risk may be in your best interest. Of course, if you feel that you have been exposed to someone sick or that you may have symptoms of the coronavirus, please be sure to contact your healthcare professional immediately. I want to wish everyone a very safe and healthy spring season.”

Online Resources

Please visit the coronavirus section of the Centers for Disease Control and Prevention (CDC) website, which provides full coverage of all the details involved with the virus, its risks, and the latest findings.
Please refer to the coronavirus section of the WebMD website for an overview of the coronavirus outbreak along with timely updates on the spread of the illness.

For More Information

For general information or to speak with a trained Client Services Specialist, please call MSAA’s Helpline at (800) 532-7667, extension 154. Questions to MSAA’s Client Services department may also be emailed to MSquestions@mymsaa.org.

Written by Susan Wells Courtney, MSAA Senior Writer
Reviewed by Dr. Barry A. Hendin, MSAA Chief Medical Officer

Friday, February 28, 2020

What You Need to Know about Coronavirus


February 27, 2020
What is the coronavirus 2019 (COVID-19)?
Coronavirus 2019 (COVID-19) is a respiratory illness  that can spread from person to person. At this time, it’s unclear how easily the virus that causes COVID-19 is spreading between people.

What are the symptoms of COVID-19?
Most people who contract COVID-19 will have mild symptoms, but some people will have more severe symptoms. Symptoms can include:
• fever
• cough
• difficulty breathing (shortness of breath)

How can I help protect myself?
There are simple everyday preventive actions to help prevent the spread of respiratory viruses.
These include
• Wash your hands often with soap and water for at least 20 seconds. Use an alcohol-based hand sanitizer that contains at least 60% alcohol if soap and water are not available.
• Avoid close contact (at least 3 feet away) with people who are sick.
• Avoid touching your eyes, nose, and mouth with unwashed hands.
• Cover your cough or sneeze with a flexed elbow or tissue, then throw the tissue in the trash.
• Clean and disinfect frequently touched objects and surfaces.

What does COVID-19 mean for people living with MS?
Many disease modifying therapies (DMTs) for MS work by modifying or suppressing the immune system. People with MS who are treated with these therapies can face an increased risk of infections. If you are taking a DMT and believe you have been exposed to COVID-19 or are confirmed to have this infection, please contact your neurologist or primary care healthcare provider.

Other resources

Thursday, July 18, 2019

New Study Links Obesity to MS, and to Worse Treatment Responses in Children and Teens


SUMMARY:
In a new study from Germany of 453 children and teens with MS, compared with more than 14,000 children without MS, those who were overweight or obese had twice the risk of developing MS, compared with non-overweight children.

They also had significantly more relapses on treatment with first-line treatments, and increased use of second-line treatment. Otherwise, there was no association found between obesity and disease activity, imaging scans, EDSS progression, or other measures.

These findings need to be confirmed with further study. It is important to note that not everyone who is obese during adolescence will develop MS, and also that many people develop MS without having been obese during adolescence.

The team (Brenda Huppke, MD, Peter Huppke, MD, and colleagues at University Medical Center Göttingen, Germany) published their findings in JAMA Neurology (posted online July 15, 2019)

DETAILS
Background: Several risk factors, including genes, exposure to infections, and environmental factors, have been identified as increasing a person’s susceptibility to developing multiple sclerosis. In addition, there is a growing body of evidence that childhood/adolescent obesity can increase the risk of developing MS. In one study, being overweight or obese was associated with an increased risk of developing MS or clinically isolated syndrome (CIS, a first clinical episode suggestive of MS, indicating increased MS risk) in girls, in a study that compared 75 children or teens with MS or CIS with the health records of more than 900,000 healthy children or teens.

Additional research is needed to understand this association. It is important to note that not everyone who is obese during adolescence will develop MS, and also that many people develop MS without having been obese during adolescence.

The Study: The researchers reviewed the medical records of 453 children and adolescents with relapsing-remitting MS. They looked at disease activity captured on imaging scans; treatment information, and EDSS scores measuring levels of physical disability. They also compared body mass index with information obtained on 14,747 children/adolescents in a Germany-wide child health survey.

Results: The team found that both boys and girls who were overweight or obese had twice the risk of developing MS, compared with non-overweight children or adolescents. Comparing responses to treatment with interferon beta or glatiramer acetate, the team reported that obese children had significantly more relapses on treatment, and were more likely to have switched to second-line treatment. Otherwise, there was no association found between obesity and disease activity, imaging scans, EDSS progression, or other measures.

The team (Brenda Huppke, MD, Peter Huppke, MD, and colleagues at University Medical Center Göttingen, Germany) published their findings in JAMA Neurology (posted online July 15, 2019)

Conclusions: This study provides strong support for a link between obesity and development of MS in both boys and girls. It also indicates a significantly worse response to first-line MS treatments and a greater likelihood of switching to second-line treatments among obese children. The authors suggest that obesity may affect pharmacokinetics – how a drug moves into, through, and out of the body. Further research is necessary to confirm these findings, and to understand the mechanism.
 

Sunday, June 30, 2019

Stem cells hold promise for MS




There is exciting and innovative research and progress occurring related to the potential of many types of stem cells for slowing MS disease activity and for repairing damage to the nervous system. In light of the urgent need for more effective treatments for MS, particularly for those with more progressive forms of the disease, we believe that the potential of all types of cell therapies must be explored.
Stem cell therapy is any treatment that uses or targets stem cells, which are the types of cells that differentiate into many different specialized cells in our bodies. Stem cells are found in both embryos and adults.
Many types of stem cells are being explored for their potential benefits for treating multiple sclerosis. Only when the results of these and subsequent clinical trials are available will it be possible to determine what the optimal cells, delivery methods, safety and actual effectiveness of these current experimental therapies might be for people with MS.

Although cell based therapy has generated a great deal of interest and holds promise, the field is in its infancy and much more research is needed before cell based therapies become a MS treatment option. 
Different Types of Stem Cells
  • HSCs (haematopoietic stem cells) – adult stem cells that are found in bone marrow and blood. HSCs are capable of producing all of the cells that make up the blood and the immune system.
  • MSCs (mesenchymal stem cells) – adult stem cells found in several places in the body, including the bone marrow, skin and fat tissue. They produce cells which help other stem cells function properly.
  • NSCs (neural stem cells) – specialized stem cells responsible for repairing nerve-insulating myelin in the brain. These can be derived from other types of stem cells such as mesenchymal cells.
  • hESCs (human embryonic stem cells) – stem cells derived from donated embryos. They can naturally produce every type of cell in the body. One concern about their potential therapeutic use is that they have been found to cause tumors.
  • iPSCs (induced pluripotent stem cells) are engineered from adult cells to produce many types of cells. One concern about their potential therapeutic use is that they have been found to cause tumors.
 National Multiple Sclerosis Society. www.NMSS.org

Wednesday, May 8, 2019

Multiple Sclerosis and CBD


Multiple Sclerosis (MS) is a disease that impacts the body’s central nervous system (CNS) including the brain, optic nerves, and spinal cord. MS consists of an abnormal response of the body’s immune system. From here, the immune system targets myelin (a substance that surrounds and insulates the body’s nerves), and myelin gets damaged, which then produces scars (sclerosis). These scars are believed to be the cause of the painful symptoms MS patients experience.

Although MS causes various painful symptoms, over 85 percent of MS patients experience spasticity. Fortunately, though, based on the studies have been conducted on cannabis and MS so far, most indicate that cannabinoids are associated with self-reported spasticity improvements. It has also been found that CBD contains anti-spasm properties. Additionally, the American Academy of Neurology has expressed that cannabis is effective for the treatment of pain and spasticity. Then, one Israel study discovered that cannabis can safely alleviate pain in older MS patients and those with other chronic conditions, such as Crohn’s Disease.

Currently, 20-60 percent of MS patients consume cannabis, and many use topical cannabis products as their primary delivery method. To help treat muscle spasms and pain, it’s common for MS patients to use cannabis topically, so they can apply the medicine onto specific areas of their body. To achieve localized and rapid relief though, it’s recommended to use topical products with one example being CanniMed’s products, from which numerous Canadian MS patients have benefited.

Sunday, December 23, 2018

Novel Molecule May be Used to Track and Treat MS


Scientists at Purdue used a novel approach to show that a molecule called acrolein is elevated in blood and urine from mice with MS-like disease and from people with MS, compared to those without the disease. Acrolein is normally a waste product, but seems to accumulate in people with neurologic disease, becoming toxic to nerve cells. They are now testing whether acrolein levels correlate with disease activity, to determine if this molecule may eventually be used to identify MS with a simple blood test. Medications targeting acrolein are already on the market, raising its potential as a therapeutic target for MS.